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Fluid resuscitation has long been considered a key intervention in the treatment of adults with severe falciparum
malaria. Profound hypovolemia is common in these patients and has the potential to exacerbate the acidosis and
acute kidney injury that are independent predictors of death. However, new microvascular imaging techniques
have shown that disease severity correlates more strongly with obstruction of the microcirculation by parasitized
erythrocytes - a process termed sequestration. Fluid loading has little effect on sequestration and increases the risk
of complications, particularly pulmonary edema, a condition that can develop suddenly and unpredictably and that
is frequently fatal in this population. Accordingly, even if a patient is clinically hypovolemic, if there is an adequate
blood pressure and urine output, there may be little advantage in infusing intravenous fluid beyond a maintenance
rate of 1 to 2 mL/kg per hour. The optimal agent for fluid resuscitation remains uncertain; significant anemia requires
blood transfusion, but colloid solutions may be associated with harm and should be avoided. The preferred crystalloid
is unclear, although the use of balanced solutions requires investigation. There are fewer data to guide the fluid
management of severe vivax and knowlesi malaria, although a similar conservative strategy would appear prudent.Introduction
More than 10% of adults with severe falciparum malaria
(SFM) requiring ICU admission will die from the disease
[1]. As this population is almost universally hypovolemic
[2,3] and the severity of lactic acidosis and the presence
of acute kidney injury (AKI) on admission to the hos-
pital are strong prognostic indicators [1,4], it has seemed
intuitive that any volume deficit in these patients should
be promptly corrected.
The implementation of guidelines that include early,
aggressive fluid loading of patients with bacterial sepsis
improves outcomes [5]. In the resource-poor setting,
prompt fluid resuscitation is a life-saving therapy for
conditions as diverse as dengue shock syndrome and
cholera [6,7]. However, unlike these conditions, hypo-
tension is relatively infrequent in SFM and is not necessar-
ily associated with increased mortality [8]. Furthermore,
fluid loading has a limited effect on the obstructed* Correspondence: drjoshhanson@gmail.com
1Menzies School of Health Research, Royal Darwin Hospital, Rocklands Drive,
Tiwi, NT 0810, Australia
2Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical
Medicine, Mahidol University, 420/6 Rajvithi Road, Bangkok 10400, Thailand
Full list of author information is available at the end of the article
© 2014 Hanson et al.; licensee BioMed Centra
for 12 months following its publication. After
Attribution License (http://creativecommons.o
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.microvascular circulation which is central to disease
pathogenesis [9], and as adults with SFM have a general-
ized increase in vascular permeability [10], fluid loading
may lead to complications. In the pulmonary circulation,
this can result in acute pulmonary edema (APO), which is
often fatal in these patients [11].
As recently as 2010, World Health Organization
(WHO) treatment guidelines observed that ‘in adults,
there is a very thin dividing line between over-hydration,
which may produce APO, and under-hydration contrib-
uting to shock, worsening acidosis and renal impair-
ment’ [12]. Against this backdrop, the best approach for
clinicians caring for patients has been unclear, resulting
in lively debate [13,14]. However, recent studies in adults
and children with SFM can now offer some guidance.
Review
Assessing volume status
The clinical assessment of a patient’s volume status is
notoriously unreliable [15,16]. In SFM, it is even more
challenging as physical signs of hypovolemia - including
tachycardia, oliguria, and confusion - can result from
the disease itself. In the PRISM (PiCCO-guided Resusci-
tation in Severe Malaria) study, in which 28 critically ill,
hypovolemic Bangladeshi and Indian adults with SFMl Ltd. The licensee has exclusive rights to distribute this article, in any medium,
this time, the article is available under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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thermodilution, physical examination failed to identify
patients who were either volume-responsive or at greater
risk of APO [17]. Recognizing the limitations of the
physical examination, the 2010 WHO treatment guide-
lines empirically recommended using a central venous
catheter (CVC) in critically ill patients and a target cen-
tral venous pressure (CVP) of 0 to 5 cm H2O [12]. How-
ever, in the Vietnamese Hemodynamic Study (VHS) of
24 adults with SFM who received fluid loading guided
by pulmonary artery occlusion pressure (PAOP), there
was no relationship between CVP and cardiac output ei-
ther before or after fluid resuscitation, and almost half
the patients with an admission CVP of not more than
0 cm H2O were not volume-responsive [18]. Similarly, in
PRISM, there was no relationship between CVP and car-
diac output before or after fluid resuscitation, and al-
most 40% of those patients with a CVP of not more
than 0 cm H2O were not volume-responsive [19].
A CVP of between 0 and 5 cm H2O also failed to pro-
tect patients against APO: the majority of patients in
PRISM and VHS with APO on enrollment had a CVP of
not more than 5 cm H2O [18,19]. There were similar find-
ings in a Thai series and in smaller series of imported mal-
aria [20-22]. These observations and the additional risks of
using CVCs have led the WHO to rescind their recom-
mendation for CVP-guided fluid resuscitation [23]. This
has coincided with a growing skepticism about the utility
of the CVP to guide fluid resuscitation in other critically
ill populations [24].
So where does this leave the clinician? Physical findings
cannot be ignored, but if used to guide fluid resuscitation,
they need to be interpreted cautiously and informed by re-
peated assessment, clinical judgment, and laboratory and
radiological investigations. In one series, transpulmonary
thermodilution appeared to be helpful as monitoring of
extravascular lung water (EVLW) during fluid loading
promptly identified incipient APO [25], but further study
is required to define its optimal role.
Contribution of volume status to clinical manifestations
Yet even if hypovolemia can be accurately identified, re-
cent data suggest a relatively limited pathological role in
adults with SFM. Every patient in PRISM was hypovol-
emic on admission when assessed with transpulmonary
thermodilution, yet the more hypovolemic patients were
actually less acidotic. Renal function was also unrelated
to volume status on admission; indeed, after 24 hours of
fluid resuscitation, the more hypovolemic patients had
lower plasma creatinine concentrations [25]. In VHS,
patients with lower systemic oxygen delivery (DO2) had
neither greater acidosis nor renal impairment [18], where-
as in a small Thai series, patients admitted with AKI had a
normal blood volume [26].Instead, it is the changes at a microvascular level, includ-
ing sequestration, endothelial dysfunction, and changes in
blood rheology, that appear more important [27] (Figure 1,
Additional file 1). Sequestration - the process in which
parasitized erythrocytes pack the microcirculation, avoid-
ing clearance by the spleen but physically obstructing
blood flow - correlated with plasma lactate concentrations
before and after resuscitation in PRISM [25] and on ad-
mission in two other Bangladeshi series [28,29]. Mean-
while, autopsy studies have shown greater renovascular
sequestration in SFM patients with AKI [30].
Conversely, features of SFM that might be attributed
to fluid excess usually exist in the absence of volume
overload. Overzealous fluid resuscitation will exacerbate
APO, but in PRISM, 70% of patients were hypovolemic
at the time it developed and the remainder were euvole-
mic [25]. Adults with cerebral malaria are universally
hypovolemic at presentation; cerebral edema can occur,
but this tends to be in the agonal setting as part of a
multi-organ dysfunction syndrome [31].
Effects of fluid resuscitation: acidosis and renal dysfunction
Two series - PRISM and VHS - examined the response
of adults with SFM to fluid resuscitation in detail
(Table 1) [18,25]. In PRISM, patients received a total of
81 fluid challenges (targeting a global end-diastolic vol-
ume index (GEDVI) of more than 680 mL/m2) but were
volume-responsive (increase in cardiac index by more
than 15%) on only 28% of these occasions; meanwhile,
50% of the patients in VHS were volume-responsive to
their single fluid challenge (which targeted a PAOP of 9
to 12 mm Hg). There was no clinically meaningful in-
crease in DO2 with fluid resuscitation in either study.
More importantly, there was no significant improvement
in acidosis, an important finding as acid–base status at
admission was the strongest prognostic indicator in both
series. Hyperchloremia from the chloride-rich fluid load
partly explained these findings, but the most important
explanation appears to be the limited effect of fluid re-
suscitation on microvascular sequestration, the principal
cause of the acidosis. Despite 6 hours of liberal fluid
loading in PRISM, 91% of patients still had visible se-
questration and in 35% the degree of sequestration was
unchanged or had increased. Sequestration was still vis-
ible in almost half of those assessed at 48 hours [25].
The persisting acidosis also resulted from the fluid load’s
failure to significantly improve renal function. In PRISM,
no anuric patient regained a urine output with fluid load-
ing and 75% later required renal replacement therapy
(RRT). In the patients with significant renal impairment
still passing urine, 50% had an increase in plasma creatin-
ine despite 24 hours of fluid resuscitation. In VHS, renal
function was as likely to deteriorate in the patients receiv-
ing a fluid bolus as in those who did not [18].
Figure 1 The appearance of microvascular sequestration with the use of different imaging techniques. (A) Photomicrograph of a brain
section from an adult Vietnamese patient who died with cerebral malaria, demonstrating blood vessels packed with parasitized erythrocytes
(hematoxylin-eosin stain, magnification × 400, courtesy Gareth Turner). (B) An electron micrograph of a capillary demonstrating microvascular
obstruction. Parasitized erythrocytes (P) obstruct the passage of an uninfected erythrocyte (U) (courtesy of Emsri Pongponratn). (C) Still from an
orthogonal polarization spectral imaging video (Additional file 1) of a patient with severe falciparum malaria, showing the cobblestone pattern of
the capillaries surrounding the rectal crypts. The polarization filter causes red structures to appear dark grey, hence erythrocytes are visible as grey
spots; their movement can be measured by using image-analysis software. The presence of sequestration is suggested in vessels where there is
no erythrocyte movement.
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renal response to fluid resuscitation was the renal func-
tion on admission. Only 5% of anuric patients regained
a urine output with fluid loading and diuretics in a
Vietnamese series [32]. In a series of Bangladeshi pa-
tients receiving fluid resuscitation guided by clinical as-
sessment, two thirds with significant renal impairment
later required RRT [33]. Patients with milder renal im-
pairment are more likely to respond, but kidney func-
tion can still deteriorate. In the Bangladeshi series, 7.4%
with a normal plasma creatinine on admission later re-
quired RRT [33]. In an Indian series, 11% of those with-
out renal failure on admission later developed the
complication [34]. Renal tubular injury is proportional
to the duration and extent of renal hypoperfusion, and
the failure of fluid resuscitation to improve renal func-
tion may be due to delays in its initiation. However,
sequestration also leads to tubular hypoperfusion, and
its persistence despite fluid and anti-malarial therapy
[25,35] may again explain why AKI continues to evolve
in some patients.Pulmonary edema and cerebral malaria
In PRISM, 74% of patients developed clinical or volu-
metric (EVLW of at least 10 mL/kg) evidence of APO
during resuscitation. All patients were hypovolemic or
euvolemic (normal GEDVI) at the point that APO devel-
oped [25]. Fluid loading was more conservative in VHS,
and clinical APO occurred less frequently [18]. These
findings suggest that increased pulmonary vascular per-
meability is common in adults with SFM and that the
risk of APO is increased by liberal fluid loading.
There is little pathological or radiological evidence that
vasogenic edema plays a major role in the pathogenesis
of cerebral malaria [31,36], a principle supported by an
absence of clinical evidence of cerebral edema in any of
the patients in PRISM [25] and the absence of neuro-
logical deterioration in any of the patients receiving fluid
loading in VHS [18].
Other clinical findings
After 24 hours of fluid resuscitation, almost 90% of pa-
tients in the PRISM study were still hypovolemic and
Table 1 Response to fluid resuscitation in the two series to specifically examine the issue in adults with severe falciparum
malaria
VHSa [18] PRISMb [25]
Baseline Post-resuscitationc Change Baseline Post-resuscitationc Change
Plasma bicarbonate, mmol/L 13.9 12.8 −0.1 16.9 12.1 −1.9
(10.5 to 17) (11.2 to 17.3) (−1 to 1) (13.8 to 17.8) (13.7 to 15.4) (−3.7 to −0.6)
Plasma lactate, mmol/L 6.3 6.3 −0.1 3.2 1.7 −1
(2.7 to 9) (2.7 to 9) (−0.6 to 0.4) (1.9 to 5.4) (1.4 to 3.1) (−1.8 to 0.3)
pHd 7.36 7.35 −0.01 7.34 7.31 −0.05
(7.29 to 7.41) (7.29 to 7.39) (−0.01 to 0.01) (7.32 to 7.37) (7.24 to 7.34) (−0.1 to 0.1)
Base deficit, mEq/L 11 13 0.6 9 13 3
(7 to 13) (6 to 14) (0.3 to 1.8) (8 to 12) (10 to 14) (0 to 5)
Strong ion gap, mEq/Le - - - 11.2 12.4 1.2
(7.2 to 15.2) (9.4 to 15.2) (−2.1 to 3.6)
CVP, cm H2O 2 5 3 5 10 6
(0 to 4) (3 to 6) (0 to 6) (−2 to 8) (7 to 14) (1 to 10)
PAOP, mm Hgf 6 11 5 - - -
(4 to 7) (8 to 12) (2 to 8)
Heart rate, beats per minute 115 111 −6 101 99 0
(100 to 130) (94 to 119) (−11 to 0) (93 to 112) (90 to 110) (−11 to 9)
Glasgow Coma Scale scoreg 8 - - 12 14 0
(6 to 13) (8 to 15) (8 to 15) (0 to 2)
MAP, mm Hg 79 79 1 88 94 7
(71 to 85) (74 to 89) (−2 to 7) (79 to 98) (82 to 108) (−2 to 17)
Cardiac index, L/min per m2 4.06 5 0.63 3.08 3.64 0.49
(3.23 to 4.82) (3.8 to 5.49) (0.15 to 1.06) (2.84 to 3.28) (3.38 to 4.13) (0.18 to 1.13)
DO2I, mL/min per m
2 454 470 18 421 403 15
(341 to 557) (371 to 578) (−21 to 87) (348 to 482) (331 to 532) (−90 to 86)
SVRI, dynes-sec/cm5 per m2 1,430 1,174 −139 2,155 1,926 −203
(1,193 to 2,039) (945 to 1,874) (−434 to −25) (1,779 to 2,532) (1,552 to 2,320) (−751 to 170)
Hemoglobin, g/dL 8.8 7.4 −0.7 10.4 9.1 −1.6
7.2 to 10.8 (6.1 to 9.7) (−1.6 to −0.1) (8.5 to 12.6) (7.1 to 10.5) (−2.5 to −0.2)
SaO2/FiO2 ratio 436 484 0 455 443 −9
(374 to 575) (360 to 552) (−25 to 25) (306 to 467) (271 to 462) (−23 to 2)
GEDVI, mL/m2e - - - 472 585 91
(429 to 571) (539 to 638) (10 to 126)
EVLW, mL/kge - - - 8 10 1
(6 to 9) (8 to 11) (1 to 3)
PVPIe - - - 2.29 2.25 0.05
(1.82 to 2.45) (1.97 to 2.6) (−0.16 to 0.32)
Plasma creatinine, μmol/Lg 339 - - 158 132 −26
(220 to 572) (106 to 255) (88 to 211) (−62 to 18)
Values are presented as the median (interquartile range). aMedian (range) of 3,230 mL (1,035 to 7,000) over the initial 6 hours and 5,450 mL (1,985 to 13,720) over
the first 24 hours. bMedian (range) fluid bolus of 918 mL (350 to 2,000) was delivered over a median (range) of 75 minutes (30 to 225). cPost-initial resuscitation in
the Vietnamese Hemodynamic Study (VHS), post-6 hours of fluid resuscitation in PiCCO-guided Resuscitation in Severe Malaria (PRISM) except plasma creatinine
which was assessed after 24 hours. dpH: arterial in VHS, central venous in PRISM. eNot measured in VHS. fNot measured in PRISM. gAs fluid load occurred over a
median of only 75 minutes in VHS, Glasgow Coma Scale score and plasma creatinine were not repeated immediately post-resuscitation. CVP, central venous
pressure; DO2I, oxygen delivery; EVLW, extravascular lung water; GEDVI, global end-diastolic volume index; MAP, mean arterial pressure; PAOP, pulmonary artery
occlusion pressure; PVPI, pulmonary vascular permeability index; SaO2/FiO2, oxygen saturation (percentage)/fraction of inspired oxygen; SVRI, systemic vascular
resistance index.
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The patients with marked edema were more likely to de-
velop APO and were more likely to die. Notably, in the
first 24 hours, there was a median fall in the intravascular
volume of the patients who later died compared with a
median increase in survivors [25]. The mechanism for this
generalized edema is uncertain, although endothelial ac-
tivation and dysfunction probably contribute. Plasma
angiopoietin-2 concentrations correlate with outcome and
disease severity in adults with malaria [37]. Endothelial ac-
tivation and sequestration may also disrupt the endothelial
glycocalyx, diminishing vascular integrity [38].
Role of intensive care unit support
However, despite the documented harm of fluid resusci-
tation, survival in PRISM and VHS was better than ex-
pected when controlled for disease severity [4]. This was
particularly notable in VHS, in which patients received
relatively inferior anti-malarial therapy (quinine or arte-
mether). Rather than suggesting any occult benefit of
fluid resuscitation, this more likely reflects the two studies’
ICU setting which facilitated access to supportive care and
well-trained clinicians. In the well-resourced ICU, mortal-
ity rates of adults with SFM are much lower [1,39].
Resuscitation strategies should also be judged by the
ease with which their complications can be remedied. It
may be better to err on the side of under-hydrating
adults with SFM as APO can occur suddenly and unpre-
dictably and is frequently fatal even if mechanical ventila-
tion is available. Conversely, AKI develops less abruptly
and has a greater therapeutic window, allowing referral to
nephrology services, where it has a better response to
treatment.
Despite the availability of mechanical ventilation, 89%
of Indian patients with an arterial partial pressure of
oxygen/fraction of inspired oxygen (PaO2/FiO2) ratio of
less than 200 mm Hg died in one large series [34] and
70% of Thai patients with a PaO2/FiO2 ratio of less than
100 mm Hg died in another [22]. Over 60% of South
African patients with APO died despite mechanical ven-
tilation [40], and even in European national referral
hospitals, patients die from malaria-related APO [39].
Conversely, in patients with AKI requiring RRT, mortal-
ity fell from 75% to 26% with a mean duration of 3 days
of peritoneal dialysis (PD) [32]. When hemofiltration
was compared with PD in Vietnamese patients with AKI
and severe infection (69% of whom had SFM), patients
receiving hemofiltration had a mortality of only 15% and
a faster resolution of acidosis and required RRT for
fewer days [41].
Multi-organ dysfunction syndrome
Although there is a tendency to categorize adults with
SFM as either ‘dry’ and at increased risk of acidosis andAKI or ‘wet’ and at increased risk of APO, this appears
too simplistic an approach. Multi-organ involvement is
the rule in the patients with the most severe disease.
Fluid management is challenging in these patients, al-
though again a more conservative approach is more
likely to be beneficial [42].
In one Indian SFM series, 69% of adults with both
AKI and APO died, the case-fatality rate was 14% if
APO occurred in isolation, and there were no deaths in
patients with only AKI [43]. In another Indian study, the
risk of death increased with both renal failure and re-
spiratory failure, but all patients with AKI alone survived
and no patient in the series had APO in isolation [34].
In a South African series, 7 out of 8 deaths occurred in
patients with concomitant AKI and APO [40], whereas
in a French series, most patients with APO had multi-
organ involvement (83% had AKI) and were more likely
to die [44]. In a Portuguese series, over three quarters of
the deaths occurred in patients with concurrent AKI and
APO [45], and in PRISM all of the patients who died had
APO while anuric [25]. In a British series, the only patient
whose death was directly attributable to malaria died of
multi-organ failure with concomitant AKI and APO [39].
Lessons from pediatric malaria
SFM has a different clinical spectrum in adults and chil-
dren: in adults, coma duration is longer, severe anemia is
less frequent, and AKI and APO are much more com-
mon [46]. However, there are important similarities in
pathophysiology in the two populations, particularly the
fundamental role of sequestration. In studies examining
the fluid resuscitation of adults and children with SFM,
there are many comparable findings.
Although hypovolemia is present in children with
SFM, it is relatively mild when assessed by using stan-
dardized measures and is not commensurate with the
degree of end-organ pathology. Gabonese children with
SFM were only mildly dehydrated when assessed isotop-
ically; despite this, over half had a plasma lactate of more
than 5 mmol/L [47]. Retinal changes consistent with se-
questration have been documented in children with SFM
and correlate with outcome and sequestration seen at aut-
opsy [48-50]. These findings suggest that, as in adults, se-
questration and endothelial dysfunction can explain the
clinical manifestations of disease in children without hypo-
volemia being invoked.
The fluid resuscitation of children with SFM has been
explored on a larger scale than in adults, culminating in
the landmark FEAST (Fluid Expansion as Supportive
Therapy) study [51]. Here, febrile African children with
clinical evidence of hypoperfusion (57% with P. falciparum
parasitemia) were randomly assigned on admission to the
hospital to receive boluses of either 20 to 40 mL/kg of 5%
albumin or 0.9% saline or to receive no boluses; standard
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to a similar degree in the children receiving an albumin or
saline bolus (relative risk of death: 1.59) compared with
the control group.
A retrospective analysis suggested that the increased
mortality resulted from cardiovascular collapse rather
than fluid overload per se, although this conclusion was
somewhat hampered by limited data regarding the par-
ticipants’ deaths. The mechanism for this cardiovascular
collapse was unclear, although a rapid reduction in sym-
pathetically mediated compensatory mechanisms and
treatment-induced hyperchloremic metabolic acidosis
were suggested. Although APO and increased intracra-
nial pressure were suspected in some patients, neither
was identified frequently [52].
Lessons from the critical care literature
The hazards of fluid resuscitation are well recognized,
and fluid excess has been linked to increased mortality
in several critically ill adult populations [53-57]. Various
hypotheses have been proposed to explain these findings.
Up to 80% of a crystalloid bolus leaves the intravascular
space of volunteers within an hour of its administrationFigure 2 Suggested fluid management for adults with severe malaria
sites where patients with severe malaria are initially managed. Early transfe
possible. Maintenance fluid: the suggested 1 to 2 mL/kg per hour should t
therapy, vasopressor infusions, and so on. Crystalloid: Based on plasma elec
crystalloid over 15 minutes; titrate bolus frequency against clinical response
pressure; RRT, renal replacement therapy, hemofiltration preferred if availab[58,59], and this figure may be higher in critically ill
adults in whom increased capillary permeability is com-
mon [60]. The resulting tissue edema might lead to organ
dysfunction by obstructing capillary and lymphatic flow
and impairing oxygen and metabolite diffusion [61,62].
Liberal fluid resuscitation is one of the central, albeit
controversial, components of the Surviving Sepsis Guide-
lines [63,64]. Although adherence to the guidelines im-
proves outcomes [65], assessing the contribution of fluid
resuscitation is complicated by the fact that it is delivered
as one component of a bundle of care including antibi-
otics, vasopressors, and expert medical and nursing care;
an independent benefit of fluid resuscitation was not iden-
tified in several studies [66,67]. Meanwhile, in patients
with acute lung injury, a restrictive fluid strategy has been
shown to improve oxygenation without an increased inci-
dence of shock or RRT requirement [42].
Even if a patient is fluid-responsive, simply increasing
DO2 is not necessarily associated with improved outcomes
[68]. If there is an adequate cardiac output and mean ar-
terial pressure - as was the case in the majority of patients
in PRISM and VHS even prior to fluid loading - what are
we expecting any extra administered fluid to do?. All of the proposed supportive care measures may not be available at
r to centers where these services are available is indicated, when
ake into consideration and include other administered fluids: antibiotic
trolytes, consider balanced solutions if available. Fluid bolus: 5 mL/kg
. APO, acute pulmonary edema; IV, intravenous; MAP, mean arterial
le.
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The WHO recommends 0.9% saline to rehydrate adults
with malaria, although recent concerns about the associ-
ation between the use of chloride-rich fluids and acidosis
and AKI may be relevant [69]. Although balanced
solutions have shown survival benefit in some ICU pop-
ulations [70], they have yet to be trialed in malaria. Few
clinical data support the use of colloids in critically ill
populations [71,72]. The fact that some preparations are
associated with an increased risk of AKI and bleeding is
concerning given the incidence of these complications in
SFM. Against this background, the current WHO recom-
mendation to treat shocked patients with plasma ex-
panders may need revision [23]. As children receiving
albumin in the FEAST study had an increased mortality, it
cannot be recommended in adults with malaria [51]. The
WHO empirically recommends a threshold for transfusion
of 7 g/dL in adults with SFM.
Suggested fluid resuscitation strategy
There is no single fluid prescription appropriate for all
adults with SFM. The disease’s protean manifestations
occur in a range of patients with a variety of co-
morbidities. However, in general, the available data sup-
port a conservative fluid resuscitation strategy (Figure 2).
Although simple extrapolation to adults is not possible,
children in the control arm of the FEAST study had the
lowest mortality and received a cumulative median fluid
load of only 10 mL/kg in the first 8 hours [51].
In the minority of adults with SFM in whom it occurs,
shock remains a medical emergency, necessitating thor-
ough assessment for concomitant bacterial infection
(with initiation of broad-spectrum antibiotics) and ex-
clusion of occult bleeding. In these patients, prompt
fluid resuscitation with frequent reassessment remains
the standard of care with early vasopressor support if re-
quired. Patients with a hemoglobin level of below 7 g/dL
should receive fresh blood or packed cells. As anemia
often evolves during treatment, clinicians should antici-
pate a transfusion requirement in those with more mod-
est anemia.
If patients are anuric, fluid resuscitation is unlikely
to lead to a recovery of renal function and early RRT
is recommended. In the setting of AKI and oliguria,
small fluid boluses (5 mL/kg titrated against effect)
could be trialed, although clinicians should maintain a
low threshold for initiating RRT. However, if an adult
with SFM has adequate blood pressure (mean arterial
blood pressure of more than 65 mm Hg) and urine
output (more than 0.5 mL/kg per hour), there appears
little advantage in prescribing any fluid beyond crystal-
loid at a maintenance rate of 1 to 2 mL/kg per hour,
with the selection of crystalloid therapy guided by plasma
electrolytes.Other malaria species
Plasmodium vivax and Plasmodium knowlesi can both
cause severe disease, although sequestration is not prom-
inent in either infection and the relative contribution of
co-morbidities to clinical manifestations, particularly in
vivax, is uncertain [73,74]. However, both infections can
cause APO with a clinical phenotype similar to that seen
in SFM. No studies of fluid resuscitation in patients with
vivax or knowlesi infection have been performed, though
given the risk of APO, a conservative fluid regimen with
early RRT and vasopressor support is recommended.
Conclusions
The optimization of volume status is a fundamental aspect
of critical care, and liberal fluid resuscitation is life-saving
in many conditions. However, in falciparum malaria, a dis-
ease with a unique pathophysiology, it is hazardous and
fails to address the microvascular obstruction seen in the
disease. Adults with SFM usually have an acceptable car-
diac output and blood pressure and are frequently not
volume-responsive; any extra administered fluid tends to
accumulate in the interstitial space, potentially exacerbat-
ing the already impaired end-organ perfusion. Liberal fluid
loading in adults leads to no meaningful improvement in
the acidosis and AKI and increases the incidence of APO,
and in children it increases mortality in the resource-poor
setting. Despite the theoretical appeal of promptly correct-
ing hypovolemia in adults with severe malaria, clinicians
caring for patients should follow the old malariologist’s
adage and ‘run them dry’.
Additional file
Additional file 1: An orthogonal polarization spectral imaging
video of a patient with severe falciparum malaria.
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